Loading clinical trials...
Loading clinical trials...
Randomized Comparison of Tissue Quality and Molecular Yield Between a Novel Crown-cut Biopsy Needle (FNB) and a Standard Aspiration Needle (FNA) for EUS Guided Diagnosis of Solid Pancreatic Lesions
The aim of this study is to compare tissue quality and molecular yield between a novel crown-cut biopsy needle (FNB) and a standard aspiration needle (FNA) for EUS-guided diagnosis of solid pancreatic lesions.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Gastro Unit, Division of Endoscopy
Herlev, Danmark, Denmark
Start Date
June 15, 2020
Primary Completion Date
April 1, 2021
Completion Date
June 1, 2021
Last Updated
December 29, 2020
68
ESTIMATED participants
ProControl, MediGlobe
DEVICE
TopGain, Medi-Globe
DEVICE
Lead Sponsor
Peter Vilmann MD, DSc, HC, FASGE
Collaborators
NCT04485286
NCT04605913
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions